BBVA USA Bancshares’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Other funds holding IDXX
BBVA USA Bancshares's IDXX Position: Q1 2021 in Review
BBVA USA Bancshares increased its Idexx Laboratories (IDXX) stake by 0.03% in Q1 2021, buying an estimated $501 and bringing the position to 3,003 shares worth $1.47M. The position accounts for 0.07% of the portfolio, ranked #250.
BBVA USA Bancshares first reported a position in IDXX in Q1 2015 and has held it in 21 quarters since. The position peaked at $1.5M in Q4 2020. 1,012 funds tracked by Wall St. Rank hold IDXX as of Q1 2021.
- BBVA USA Bancshares held 3,003 shares of Idexx Laboratories worth $1.47M as of Q1 2021.
- BBVA USA Bancshares bought 1 Idexx Laboratories share in Q1 2021, an estimated $501.
- Idexx Laboratories made up 0.07% of BBVA USA Bancshares's portfolio in Q1 2021, its #250 holding.
- BBVA USA Bancshares first reported a position in Idexx Laboratories in Q1 2015 and has held it in 21 quarters since.
- BBVA USA Bancshares's Idexx Laboratories position peaked at $1.5M in Q4 2020.
- 1,012 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2021.
Based on BBVA USA Bancshares's 13F filing for Q1 2021, filed 23 Apr 2021.